JP2020514368A5 - - Google Patents

Download PDF

Info

Publication number
JP2020514368A5
JP2020514368A5 JP2019550764A JP2019550764A JP2020514368A5 JP 2020514368 A5 JP2020514368 A5 JP 2020514368A5 JP 2019550764 A JP2019550764 A JP 2019550764A JP 2019550764 A JP2019550764 A JP 2019550764A JP 2020514368 A5 JP2020514368 A5 JP 2020514368A5
Authority
JP
Japan
Prior art keywords
antibody
time point
xviii
collagen
hemophiliac
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019550764A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020514368A (ja
JP7275040B2 (ja
Filing date
Publication date
Priority claimed from GBGB1704182.3A external-priority patent/GB201704182D0/en
Application filed filed Critical
Publication of JP2020514368A publication Critical patent/JP2020514368A/ja
Publication of JP2020514368A5 publication Critical patent/JP2020514368A5/ja
Application granted granted Critical
Publication of JP7275040B2 publication Critical patent/JP7275040B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019550764A 2017-03-16 2018-03-14 Ｘｖｉｉｉ型コラーゲンアッセイ Active JP7275040B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1704182.3A GB201704182D0 (en) 2017-03-16 2017-03-16 Collagen tye XVIII assay
GB1704182.3 2017-03-16
PCT/EP2018/056320 WO2018167111A1 (en) 2017-03-16 2018-03-14 Collagen type xviii assay

Publications (3)

Publication Number Publication Date
JP2020514368A JP2020514368A (ja) 2020-05-21
JP2020514368A5 true JP2020514368A5 (https=) 2021-04-30
JP7275040B2 JP7275040B2 (ja) 2023-05-17

Family

ID=58688412

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019550764A Active JP7275040B2 (ja) 2017-03-16 2018-03-14 Ｘｖｉｉｉ型コラーゲンアッセイ

Country Status (6)

Country Link
US (2) US20200087385A1 (https=)
EP (1) EP3596120B1 (https=)
JP (1) JP7275040B2 (https=)
ES (1) ES2969042T3 (https=)
GB (1) GB201704182D0 (https=)
WO (1) WO2018167111A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201901710D0 (en) * 2019-02-07 2019-03-27 Nordic Bioscience As Collagen type 23 assay
GB202019578D0 (en) * 2020-12-11 2021-01-27 Nordic Bioscience As Assay for detecting Collagen XVIII biomarkers

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2007049749A1 (ja) * 2005-10-28 2009-04-30 ディナベック株式会社 血液凝固異常の治療方法

Similar Documents

Publication Publication Date Title
JP2007525427A5 (https=)
CN103703370B (zh) 诊断性肽的检测
JP6669794B2 (ja) 腎機能の診断若しくは監視又は腎機能障害の診断方法
US11719697B2 (en) Immunoassay and antibodies for the detection of chromogranin A
US9034591B2 (en) Immunoassay for quantification of an unstable antigen selected from BNP and proBNP
US20180017576A1 (en) Compounds and methods for the detection of calprotectin
CN102159953A (zh) 作为心脏疾病标志物的嗜苯胺蓝颗粒蛋白酶
RU2017114626A (ru) Антитело, связывающее линейный эпитоп человеческого р53, и его применение в диагностике
JP2020514368A5 (https=)
CN108738347B (zh) 辅助肝细胞癌患者的再发风险预测的方法、装置、计算机程序制品及试剂盒
JP2022031783A (ja) ＡＰＰ６６９－ｘのＮ末端を特異的に認識する抗体、及び免疫測定法
CN104781672A (zh) 预测女性对象患癌症风险或诊断其癌症的方法
JP6249712B2 (ja) 非傍腫瘍性急性脳炎患者の予後診断装置の作動方法
JP2020514369A5 (https=)
US20220202828A1 (en) Insulin-like growth factor axis proteins as circulating pulmonary arterial hypertension biomarkers
US11267854B2 (en) Complex-specific standardization of immunological methods for the quantification of S100A12
WO2019167128A1 (ja) サンドイッチ型免疫測定法
JP2017526924A5 (https=)
JP2011257147A (ja) データ収集方法、キット及び腫瘍マーカー
JPWO2023079130A5 (https=)
WO2014029816A1 (en) Anti-c1q epitope elisa
JPWO2022263675A5 (https=)
HK1229425B (en) Immunoassay for the detection of chromogranin a
HK1229425A1 (en) Immunoassay for the detection of chromogranin a
HK1147801A (en) Immunoassay for quantification of an unstable antigen selected from bnp and probnp